Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes
Ishant Khurana(Baker Heart and Diabetes Institute), Assam El‐Osta(University of Copenhagen), Soontaree Nakasatien(Bangkok Hospital), Merlin C. Thomas(Monash University), Tine W. Hansen(Steno Diabetes Centers), Mark Ziemann(Baker Heart and Diabetes Institute), Keith Al‐Hasani(John Radcliffe Hospital), Heung Man Lee(Chinese University of Hong Kong), Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Thep Himathongkam(Bangkok Hospital), Anna Syreeni(Helsinki University Hospital), Anne Jørgensen(Steno Diabetes Centers), Andrea O. Y. Luk(Chinese University of Hong Kong), Christopher L. Fogarty(University of Helsinki), Scott Maxwell(Baker Heart and Diabetes Institute), Antony Kaspi(Walter and Eliza Hall Institute of Medical Research), Assaad A. Eid(American University of Beirut Medical Center), Sørine Birkelund(University College Copenhagen), Jun Okabe(Monash University), Guozhi Jiang(Broad Institute), Nete Tofte(Steno Diabetes Centers), Harikrishnan Kaipananickal(Baker Heart and Diabetes Institute), Yotsapon Thewjitcharoen(Diabetes Australia), Peter Rossing(Steno Diabetes Centers), Juliana C.N. Chan(Chinese University of Hong Kong), Evy C. Ottesen(Steno Diabetes Centers), Ronald C.W.(Chinese University of Hong Kong), Mark E. Cooper(Monash University), Rachel Njeim(American University of Beirut), Yü Huang(University of California, Los Angeles), Haloom Rafehi(The University of Melbourne)
Cited by 41
Related Papers
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
|New England Journal of Medicine|2024|1.5k